title: Targeting HCC Therapy: On or Off ToPiX?
authors.affiliation: Departments of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA, claudia.andl@vanderbilt.edu.
authors.forename: Claudia D
authors.initials: CD
authors.lastname: Andl
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D006528:Carcinoma, Hepatocellular / Q000503:physiopathology*; D018797:Cell Cycle Proteins / Q000097:blood*; D049109:Cell Proliferation / Q000502:physiology*; D058750:Epithelial-Mesenchymal Transition / Q000502:physiology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000503:physiopathology*; D008297:Male; D008869:Microtubule-Associated Proteins / Q000097:blood*; D009687:Nuclear Proteins / Q000097:blood*
chemical_list: D018797:Cell Cycle Proteins; D008869:Microtubule-Associated Proteins; D009687:Nuclear Proteins